Rafferty Asset Management, LLC Axsome Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

$26.8 Billion
Q2 2024

A detailed history of Rafferty Asset Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 5,477 shares of AXSM stock, worth $495,723. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,477

Previous 6,862 20.18%

Holding current value

$495,723

Previous $547,000 19.56%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$65.72 - $80.5 $91,022 - $111,492	-1,385 Reduced 20.18%	5,477 $440,000
Q1 2024 May 13, 2024	BUY	$69.39 - $97.64 $71,124 - $100,081	1,025 Added 17.56%	6,862 $547,000
Q4 2023 Feb 13, 2024	BUY	$57.42 - $83.61 $73,325 - $106,769	1,277 Added 28.0%	5,837 $464,000
Q3 2023 Nov 13, 2023	BUY	$69.25 - $82.21 $14,196 - $16,853	205 Added 4.71%	4,560 $318,000
Q2 2023 Aug 11, 2023	SELL	$58.41 - $90.35 $9,228 - $14,275	-158 Reduced 3.5%	4,355 $312,000
Q1 2023 May 11, 2023	BUY	$58.39 - $75.0 $32,464 - $41,700	556 Added 14.05%	4,513 $278,000
Q4 2022 Feb 13, 2023	BUY	$39.94 - $79.72 $158,042 - $315,452	3,957 New	3,957 $305,000
Q2 2022 Aug 12, 2022	BUY	$21.74 - $46.75 $92,242 - $198,360	4,243 Added 77.27%	9,734 $373,000
Q1 2022 May 13, 2022	SELL	$23.7 - $41.39 $257,168 - $449,122	-10,851 Reduced 66.4%	5,491 $227,000
Q4 2021 Feb 10, 2022	SELL	$30.7 - $43.36 $33,033 - $46,655	-1,076 Reduced 6.18%	16,342 $617,000
Q3 2021 Nov 10, 2021	BUY	$19.91 - $68.26 $275,255 - $943,694	13,825 Added 384.78%	17,418 $574,000
Q2 2021 Aug 10, 2021	BUY	$50.63 - $73.5 $181,913 - $264,085	3,593 New	3,593 $242,000
Q1 2021 May 10, 2021	SELL	$55.91 - $81.44 $222,745 - $324,456	-3,984 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$66.31 - $86.52 $5,636 - $7,354	-85 Reduced 2.09%	3,984 $325,000
Q3 2020 Nov 13, 2020	SELL	$68.34 - $85.84 $4,510 - $5,665	-66 Reduced 1.6%	4,069 $290,000
Q2 2020 Aug 07, 2020	BUY	$49.87 - $98.69 $206,212 - $408,083	4,135 New	4,135 $340,000
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $187,254 - $460,453	-4,545 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$16.71 - $106.24 $138,442 - $880,198	-8,285 Reduced 64.58%	4,545 $470,000
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $259,679 - $374,122	12,830 New	12,830 $260,000

Others Institutions Holding AXSM

# of Institutions

288

Shares Held

40.4M

Call Options Held

365K

Put Options Held

428K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.88B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Axsome Therapeutics, Inc. Transaction History